Clinical Trial

Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-02 -> 2026-09-30 2026-06-30
minor Completion pushed: 2026-02 -> 2026-12 2026-06-30
Trial Details
NCT Number NCT06396416
Lead Sponsor Western University, Canada
Collaborators: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Queen Elizabeth II Health Sciences Centre, Unity Health Toronto
Conditions Obesity, Chronic Kidney Disease
Enrollment 60 participants
Start Date 2024-09-26
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-29